labels, including security, standard, and specialty types, and package inserts.prescription containers, including plastic vials, blister packs, and other types.secondary containers, including folding boxes and cartons, corrugated shipping containers, and other consisting of thermoformed kits and trays, and blister and clamshell packs.closures, including plastic, metal, and other types in child-resistant, tamper evident, and other formats.primary containers, including plastic bottles, blister packaging, prefillable syringes, parenteral vials and ampuls, prefillable inhalers, pouches, medication tubes, IV containers, glass bottles and jars, and other containers, such as strip packs, paperboard boxes, and various specialty containers.Products covered under the scope of this study include: Featuring 104 tables and 46 figures – now available in Excel and Powerpoint! Learn More The remaining 70% consisted of finished containers, closures, and accessories supplied by packaging manufacturers or contract packaging firms. In 2018, the estimated value of captive production by drug makers amounted to approximately 30% of global pharmaceutical packaging demand. This detailed study examines the global market for pharmaceutical packaging containers, closures, and accessories.įor purposes of this study, pharmaceutical packaging product demand is defined as the value of finished containers, closures, and accessories sold by merchant companies and produced or assembled internally by pharmaceutical manufacturers and contract packaging firms. Add to Cart How will the COVID-19 coronavirus impact the global economy? The Freedonia Group is tracking recent developments and analyzing their impact in an easy to follow Economic Impact Tracker.
0 kommentar(er)
